Improvement of cardiovascular risk prediction: time to review current knowledge,debates,and fundamentals on how to assess test characteristics

Abstract

Cardiovascular risk assessment might be improved with the addition of emerging, new tests derived from atherosclerosis imaging, laboratory tests or functional tests. This article reviews relative risk, odds ratios, receiver-operating curves, posttest risk calculations based on likelihood ratios, the net reclassification improvement and integrated discrimination. This serves to determine whether a new test has an added clinical value on top of conventional risk testing and how this can be verified statistically. Two clinically meaningful examples serve to illustrate novel approaches. This work serves as a review and basic work for the development of new guidelines on cardiovascular risk prediction, taking into account emerging tests, to be proposed by members of the ‘Taskforce on Vascular Risk Prediction’ under the auspices of the Working Group ‘Swiss Atherosclerosis’ of the Swiss Society of Cardiology in the future.

Keywords

myocardial infarction risk prediction statistical methods

Get full access to this article

View all access options for this article.

References

Riesen

Darioli

Noseda

Bertel

Buser

Recommendations for the prevention of atherosclerosis. Schweiz Aerztezeitung 2005; 86:1355–1361.

Von Eckardstein

Schulte

Assmann

Comparison of international consensus recommendations for the detection of healthy risk subjects at high risk for myocardial infarction in Germany. Zeitschrift fUr Kardiologie 2005; 94:52–60.

3 Conroy

Pyörälä

Fitzgerald

Sans

Menotti

De Backer

, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987–1003.

Richter

Lange

Methods for the evaluation of a diagnosis. Internist 1997; 38:325–336.

Steurer

Expressions with high importance for the interpretation of scientific papers dealing with the description of a diagnostic test. Schweiz Rundschau Med Praxis 1997; 86:945.

Speich

The process of obtaining a diagnosis in internal medicine: decision analysis or intuition? Lecture at the Zurich University, April 4th 1996. Schweiz Med Wochenschr 1997; 127:1263–1279.

Glenck

Pewsner

Bucher

Evidence-based medicine: how do I evaluate a study about the value of a diagnostic test. Schweiz Med Forum 2001; 9:213–220.

8 Assmann

Cullen

Fruchart

Greten

Naruszewicz

Olsson

, et al. Implications of emerging risk factors for therapeutic intervention. Nutr Metab Cardiovasc Dis 2005; 15:373–381.

9 Naghavi

Falk

Hecht

Jamieson

Kaul

Berman

, et al. From vulnerable plaque to vulnerable patient—part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am J Cardiol 2006; 98 (Suppl):2H–15H.

10.

Cook

Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928–935.

11.

Sackett

Strauss

Richardson

Rosenberg

Haynes

Evidence-based medicine. How to practice and teach EBM. 2nd ed. New York, Edinburgh, London, Toronto, Philadelphia, St. Louis, Sidney: Churchill Livingstone; 2000.

12.

Ridker

Rifai

Rose

Buring

Cook

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557–1565.

13.

13 O'Leary

Wolfson

Kronmal

Manolio

Burke

Wolfson

, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 240:14–22.

14.

14 Folsom

Chambless

Ballantyne

Coresh

Heiss

, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers. The atherosclerosis risk in communities study. Arch Intern Med 2006; 166:1368–1373.

15.

Miller

Zhan

Havas

High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors. The Third National Health and Nutrition Examination Survey. Arch Intern Med 2005; 165:2063–2068.

16.

16 Del Sol

Moons

Hollander

Hofman

Koudstaal

Grobbee

, et al. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? Stroke 2001; 32:1532–1538.

17.

Pencina

D'Agostino

Jr Vasan

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157–172.

18.

Newcombe

RG.

Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17:873–890.

19.

Bayes

ET.

An assay toward solving a problem in the doctrin of chance. Philos Trans R Soc Lond (Biol) 1763; 53:370–418.

20.

Fagan

TJ.

Nomogram for Bayes theorem. N Engl J Med 1975; 293:257.

21.

Martikainen

Ottelin

Kiviniemi

Gylling

Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach. Eur J Cardiovas Prevent Rehabil 2007; 14:265–272.

22.

Khairy

Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. www.nature.com/ clinicalpractice. doi:10.1038/ncpcardio0882.

23.

Spence

Eliasziw

Di Cicco

Hackam

Lohmann

Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33:2916–2922.

24.

Greenland

The need for reorientation toward cost-effective prediction: comments on evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond by Pencina M.J. et al. Stat Med 2008; 27:199–206.